Zhang, Peize
Shi, Huaifang
Xie, Yongping
Liang, Jiemei
Hu, Qiumeng
Fu, Liang
Wang, Yuxiang
Tan, Jie
Zhan, Senlin
Qin, Hongjuan
Xu, Guanghui
Deng, Guofang
Funding for this research was provided by:
The National Natural Science Foundation of China (No. 82070016)
The Guangdong Provincial Clinical Research Center for Tuberculosis (No. 2020B1111170014)
The Shenzhen Clinical Research Center for Tuberculosis (No. 20210617141509001)
Article History
Received: 8 August 2024
Accepted: 4 September 2024
First Online: 27 September 2024
Declarations
:
: The trial received ethical approval from the Institutional Review Boards of Shenzhen Third People’s Hospital (approval number 2021-014-02) and other participating sites. Participants must provide signed and dated written informed consent prior to undergoing any study-specific procedures.
: Not applicable.
: The authors declare no competing interests.
: Recruitment began at the first site in June 2021 and is expected to be completed by December 2024.